Efficacy and safety of KRd or KCd induction in multiple myeloma
Efficacy and safety of KRd or KCd induction in multiple myeloma
Clinical impact of an accurate genetic characterisation of older AML patients
Circulating tumour-cell count used to decide between treatments for breast cancer patients
Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer
Low-dose tamoxifen reduces recurrence and new breast disease
Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients
Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients
Two clinical trials using combination therapy in adult patients with multiple myeloma
Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas
Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL
Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia